nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLC22A1—prostate cancer	0.121	0.37	CbGaD
Nelfinavir—CYP3A5—prostate cancer	0.0977	0.298	CbGaD
Nelfinavir—CYP2C19—prostate cancer	0.0665	0.203	CbGaD
Nelfinavir—CYP3A4—prostate cancer	0.0423	0.129	CbGaD
Nelfinavir—SLCO1A2—Estrone—prostate cancer	0.0193	0.0413	CbGbCtD
Nelfinavir—SLCO1B1—Cabazitaxel—prostate cancer	0.0186	0.0399	CbGbCtD
Nelfinavir—SLCO1B1—Estrone—prostate cancer	0.0182	0.039	CbGbCtD
Nelfinavir—ABCG2—Cabazitaxel—prostate cancer	0.0148	0.0317	CbGbCtD
Nelfinavir—ABCG2—Estrone—prostate cancer	0.0144	0.031	CbGbCtD
Nelfinavir—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0126	0.027	CbGbCtD
Nelfinavir—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0119	0.0255	CbGbCtD
Nelfinavir—SLCO1A2—Estradiol—prostate cancer	0.0111	0.0237	CbGbCtD
Nelfinavir—CYP3A5—Flutamide—prostate cancer	0.0111	0.0237	CbGbCtD
Nelfinavir—CYP2C19—Nilutamide—prostate cancer	0.0108	0.0231	CbGbCtD
Nelfinavir—CYP2C19—Bicalutamide—prostate cancer	0.0108	0.0231	CbGbCtD
Nelfinavir—SLCO1B1—Estradiol—prostate cancer	0.0104	0.0224	CbGbCtD
Nelfinavir—CYP2B6—Estrone—prostate cancer	0.0102	0.0218	CbGbCtD
Nelfinavir—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00991	0.0213	CbGbCtD
Nelfinavir—SLC22A1—Estradiol—prostate cancer	0.00976	0.0209	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—prostate cancer	0.00951	0.0204	CbGbCtD
Nelfinavir—ABCG2—Conjugated Estrogens—prostate cancer	0.00944	0.0203	CbGbCtD
Nelfinavir—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00905	0.0194	CbGbCtD
Nelfinavir—CYP2C9—Bicalutamide—prostate cancer	0.00895	0.0192	CbGbCtD
Nelfinavir—CYP2C9—Nilutamide—prostate cancer	0.00895	0.0192	CbGbCtD
Nelfinavir—CYP2C19—Flutamide—prostate cancer	0.00892	0.0192	CbGbCtD
Nelfinavir—ABCG2—Mitoxantrone—prostate cancer	0.00858	0.0184	CbGbCtD
Nelfinavir—ABCG2—Estradiol—prostate cancer	0.00829	0.0178	CbGbCtD
Nelfinavir—CYP1A2—Flutamide—prostate cancer	0.00823	0.0177	CbGbCtD
Nelfinavir—CYP2D6—Bicalutamide—prostate cancer	0.00819	0.0176	CbGbCtD
Nelfinavir—CYP3A5—Cabazitaxel—prostate cancer	0.00818	0.0176	CbGbCtD
Nelfinavir—ABCB1—Estramustine—prostate cancer	0.00808	0.0173	CbGbCtD
Nelfinavir—CYP3A5—Estrone—prostate cancer	0.008	0.0172	CbGbCtD
Nelfinavir—CYP2D6—Abiraterone—prostate cancer	0.00678	0.0146	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00612	0.0131	CbGbCtD
Nelfinavir—CYP3A7—Estradiol—prostate cancer	0.00612	0.0131	CbGbCtD
Nelfinavir—CYP1A2—Estrone—prostate cancer	0.00595	0.0128	CbGbCtD
Nelfinavir—ABCG2—Etoposide—prostate cancer	0.00541	0.0116	CbGbCtD
Nelfinavir—CYP2C9—Estrone—prostate cancer	0.00536	0.0115	CbGbCtD
Nelfinavir—ABCB1—Cabazitaxel—prostate cancer	0.00532	0.0114	CbGbCtD
Nelfinavir—CYP3A4—Bicalutamide—prostate cancer	0.0052	0.0112	CbGbCtD
Nelfinavir—ABCB1—Estrone—prostate cancer	0.0052	0.0112	CbGbCtD
Nelfinavir—ABCG2—Docetaxel—prostate cancer	0.00495	0.0106	CbGbCtD
Nelfinavir—CYP3A4—Estramustine—prostate cancer	0.00484	0.0104	CbGbCtD
Nelfinavir—ABCB1—Ethinyl Estradiol—prostate cancer	0.00464	0.00996	CbGbCtD
Nelfinavir—CYP3A5—Estradiol—prostate cancer	0.00459	0.00986	CbGbCtD
Nelfinavir—CYP3A4—Abiraterone—prostate cancer	0.00431	0.00926	CbGbCtD
Nelfinavir—CYP3A4—Flutamide—prostate cancer	0.00431	0.00926	CbGbCtD
Nelfinavir—CYP2C9—Capecitabine—prostate cancer	0.00406	0.00873	CbGbCtD
Nelfinavir—CYP1A2—Conjugated Estrogens—prostate cancer	0.00389	0.00836	CbGbCtD
Nelfinavir—CYP2C19—Estradiol—prostate cancer	0.0037	0.00795	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—prostate cancer	0.00369	0.00793	CbGbCtD
Nelfinavir—CYP3A7—Docetaxel—prostate cancer	0.00366	0.00785	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00366	0.00785	CbGbCtD
Nelfinavir—CYP1A2—Estradiol—prostate cancer	0.00342	0.00734	CbGbCtD
Nelfinavir—ABCB1—Conjugated Estrogens—prostate cancer	0.0034	0.00731	CbGbCtD
Nelfinavir—CYP3A4—Cabazitaxel—prostate cancer	0.00319	0.00685	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—prostate cancer	0.00319	0.00684	CbGbCtD
Nelfinavir—CYP3A4—Estrone—prostate cancer	0.00312	0.0067	CbGbCtD
Nelfinavir—ABCB1—Mitoxantrone—prostate cancer	0.00309	0.00665	CbGbCtD
Nelfinavir—CYP2C9—Estradiol—prostate cancer	0.00308	0.00661	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—prostate cancer	0.003	0.00644	CbGbCtD
Nelfinavir—ABCB1—Estradiol—prostate cancer	0.00299	0.00642	CbGbCtD
Nelfinavir—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00278	0.00597	CbGbCtD
Nelfinavir—CYP3A5—Docetaxel—prostate cancer	0.00274	0.00589	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—prostate cancer	0.0026	0.00557	CbGbCtD
Nelfinavir—ABCB1—Prednisone—prostate cancer	0.00257	0.00552	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—prostate cancer	0.00223	0.00479	CbGbCtD
Nelfinavir—CYP3A4—Conjugated Estrogens—prostate cancer	0.00204	0.00438	CbGbCtD
Nelfinavir—ABCB1—Etoposide—prostate cancer	0.00195	0.00419	CbGbCtD
Nelfinavir—CYP3A4—Mitoxantrone—prostate cancer	0.00185	0.00398	CbGbCtD
Nelfinavir—CYP3A4—Estradiol—prostate cancer	0.00179	0.00385	CbGbCtD
Nelfinavir—ABCB1—Docetaxel—prostate cancer	0.00179	0.00383	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—prostate cancer	0.00154	0.00331	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—prostate cancer	0.00133	0.00286	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—prostate cancer	0.00125	0.00269	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—prostate cancer	0.00117	0.00251	CbGbCtD
Nelfinavir—CYP2C19—urine—prostate cancer	0.00114	0.121	CbGeAlD
Nelfinavir—CYP3A4—Docetaxel—prostate cancer	0.00107	0.0023	CbGbCtD
Nelfinavir—CYP1A2—urine—prostate cancer	0.000935	0.0988	CbGeAlD
Nelfinavir—CYP2C9—urine—prostate cancer	0.000888	0.0938	CbGeAlD
Nelfinavir—CYP3A4—Doxorubicin—prostate cancer	0.000798	0.00171	CbGbCtD
Nelfinavir—CYP3A4—urine—prostate cancer	0.000677	0.0715	CbGeAlD
Nelfinavir—CYP2D6—urine—prostate cancer	0.000666	0.0704	CbGeAlD
Nelfinavir—Indinavir—SLC22A1—prostate cancer	0.000491	0.212	CrCbGaD
Nelfinavir—SLCO1B1—renal system—prostate cancer	0.00043	0.0454	CbGeAlD
Nelfinavir—Indinavir—CYP3A5—prostate cancer	0.000396	0.171	CrCbGaD
Nelfinavir—Saquinavir—SLC22A1—prostate cancer	0.000367	0.158	CrCbGaD
Nelfinavir—SLC22A1—renal system—prostate cancer	0.000363	0.0384	CbGeAlD
Nelfinavir—SLCO1A2—renal system—prostate cancer	0.00035	0.037	CbGeAlD
Nelfinavir—ABCG2—prostate gland—prostate cancer	0.000349	0.0368	CbGeAlD
Nelfinavir—CYP3A5—prostate gland—prostate cancer	0.000324	0.0342	CbGeAlD
Nelfinavir—Saquinavir—CYP3A5—prostate cancer	0.000296	0.127	CrCbGaD
Nelfinavir—ABCG2—seminal vesicle—prostate cancer	0.000295	0.0312	CbGeAlD
Nelfinavir—Indinavir—CYP2C19—prostate cancer	0.00027	0.116	CrCbGaD
Nelfinavir—ABCG2—urethra—prostate cancer	0.000234	0.0247	CbGeAlD
Nelfinavir—CYP1A2—renal system—prostate cancer	0.000229	0.0242	CbGeAlD
Nelfinavir—SLCO1A2—testis—prostate cancer	0.000226	0.0239	CbGeAlD
Nelfinavir—CYP3A5—renal system—prostate cancer	0.000221	0.0233	CbGeAlD
Nelfinavir—CYP2B6—renal system—prostate cancer	0.000219	0.0232	CbGeAlD
Nelfinavir—Saquinavir—CYP2C19—prostate cancer	0.000201	0.0868	CrCbGaD
Nelfinavir—ABCG2—bone marrow—prostate cancer	0.00018	0.019	CbGeAlD
Nelfinavir—ABCB1—prostate gland—prostate cancer	0.000172	0.0182	CbGeAlD
Nelfinavir—Indinavir—CYP3A4—prostate cancer	0.000171	0.0739	CrCbGaD
Nelfinavir—CYP3A4—renal system—prostate cancer	0.000166	0.0175	CbGeAlD
Nelfinavir—CYP2D6—renal system—prostate cancer	0.000163	0.0172	CbGeAlD
Nelfinavir—ABCG2—testis—prostate cancer	0.000154	0.0162	CbGeAlD
Nelfinavir—ABCB1—seminal vesicle—prostate cancer	0.000145	0.0154	CbGeAlD
Nelfinavir—CYP2B6—testis—prostate cancer	0.000142	0.015	CbGeAlD
Nelfinavir—Saquinavir—CYP3A4—prostate cancer	0.000128	0.0552	CrCbGaD
Nelfinavir—ABCB1—epithelium—prostate cancer	0.000126	0.0134	CbGeAlD
Nelfinavir—ABCB1—renal system—prostate cancer	0.000117	0.0124	CbGeAlD
Nelfinavir—ABCB1—urethra—prostate cancer	0.000115	0.0122	CbGeAlD
Nelfinavir—ABCG2—lymph node—prostate cancer	0.000111	0.0118	CbGeAlD
Nelfinavir—CYP2D6—testis—prostate cancer	0.000105	0.0111	CbGeAlD
Nelfinavir—ABCB1—bone marrow—prostate cancer	8.86e-05	0.00936	CbGeAlD
Nelfinavir—ABCB1—testis—prostate cancer	7.58e-05	0.008	CbGeAlD
Nelfinavir—ABCB1—lymph node—prostate cancer	5.49e-05	0.0058	CbGeAlD
Nelfinavir—Gastrointestinal disorder—Etoposide—prostate cancer	4.47e-05	0.000394	CcSEcCtD
Nelfinavir—Asthenia—Mitoxantrone—prostate cancer	4.47e-05	0.000394	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.46e-05	0.000393	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—prostate cancer	4.44e-05	0.000391	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—prostate cancer	4.44e-05	0.000391	CcSEcCtD
Nelfinavir—Pain—Etoposide—prostate cancer	4.43e-05	0.00039	CcSEcCtD
Nelfinavir—Dizziness—Estradiol—prostate cancer	4.42e-05	0.000389	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—prostate cancer	4.42e-05	0.000389	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—prostate cancer	4.37e-05	0.000384	CcSEcCtD
Nelfinavir—Arthralgia—Capecitabine—prostate cancer	4.35e-05	0.000383	CcSEcCtD
Nelfinavir—Myalgia—Capecitabine—prostate cancer	4.35e-05	0.000383	CcSEcCtD
Nelfinavir—Anxiety—Capecitabine—prostate cancer	4.33e-05	0.000382	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.32e-05	0.00038	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—prostate cancer	4.31e-05	0.000379	CcSEcCtD
Nelfinavir—Oedema—Docetaxel—prostate cancer	4.31e-05	0.000379	CcSEcCtD
Nelfinavir—Discomfort—Capecitabine—prostate cancer	4.3e-05	0.000378	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—prostate cancer	4.29e-05	0.000378	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—prostate cancer	4.27e-05	0.000376	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—prostate cancer	4.27e-05	0.000376	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—prostate cancer	4.26e-05	0.000375	CcSEcCtD
Nelfinavir—Diarrhoea—Mitoxantrone—prostate cancer	4.26e-05	0.000375	CcSEcCtD
Nelfinavir—Vomiting—Estradiol—prostate cancer	4.25e-05	0.000374	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—prostate cancer	4.24e-05	0.000373	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—prostate cancer	4.24e-05	0.000373	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisone—prostate cancer	4.22e-05	0.000372	CcSEcCtD
Nelfinavir—Thrombocytopenia—Docetaxel—prostate cancer	4.22e-05	0.000371	CcSEcCtD
Nelfinavir—Rash—Estradiol—prostate cancer	4.21e-05	0.000371	CcSEcCtD
Nelfinavir—Dermatitis—Estradiol—prostate cancer	4.21e-05	0.000371	CcSEcCtD
Nelfinavir—Anaemia—Prednisone—prostate cancer	4.2e-05	0.00037	CcSEcCtD
Nelfinavir—Headache—Estradiol—prostate cancer	4.19e-05	0.000369	CcSEcCtD
Nelfinavir—Skin disorder—Docetaxel—prostate cancer	4.18e-05	0.000368	CcSEcCtD
Nelfinavir—Agitation—Prednisone—prostate cancer	4.18e-05	0.000368	CcSEcCtD
Nelfinavir—Oedema—Capecitabine—prostate cancer	4.17e-05	0.000367	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—prostate cancer	4.12e-05	0.000362	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—prostate cancer	4.11e-05	0.000362	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—prostate cancer	4.11e-05	0.000362	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—prostate cancer	4.11e-05	0.000362	CcSEcCtD
Nelfinavir—Anorexia—Docetaxel—prostate cancer	4.1e-05	0.000361	CcSEcCtD
Nelfinavir—Malaise—Prednisone—prostate cancer	4.1e-05	0.000361	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—prostate cancer	4.1e-05	0.000361	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—prostate cancer	4.1e-05	0.000361	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—prostate cancer	4.1e-05	0.000361	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—prostate cancer	4.09e-05	0.00036	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—prostate cancer	4.09e-05	0.00036	CcSEcCtD
Nelfinavir—Thrombocytopenia—Capecitabine—prostate cancer	4.08e-05	0.000359	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—prostate cancer	4.06e-05	0.000357	CcSEcCtD
Nelfinavir—Skin disorder—Capecitabine—prostate cancer	4.05e-05	0.000357	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—prostate cancer	4.04e-05	0.000356	CcSEcCtD
Nelfinavir—Hyperhidrosis—Capecitabine—prostate cancer	4.03e-05	0.000355	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—prostate cancer	4.02e-05	0.000354	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—prostate cancer	3.98e-05	0.000351	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—prostate cancer	3.97e-05	0.00035	CcSEcCtD
Nelfinavir—Anorexia—Capecitabine—prostate cancer	3.97e-05	0.00035	CcSEcCtD
Nelfinavir—Nausea—Estradiol—prostate cancer	3.97e-05	0.00035	CcSEcCtD
Nelfinavir—Vomiting—Mitoxantrone—prostate cancer	3.96e-05	0.000349	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—prostate cancer	3.95e-05	0.000348	CcSEcCtD
Nelfinavir—Convulsion—Prednisone—prostate cancer	3.94e-05	0.000347	CcSEcCtD
Nelfinavir—Rash—Mitoxantrone—prostate cancer	3.93e-05	0.000346	CcSEcCtD
Nelfinavir—Dermatitis—Mitoxantrone—prostate cancer	3.92e-05	0.000346	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.92e-05	0.000345	CcSEcCtD
Nelfinavir—Headache—Mitoxantrone—prostate cancer	3.9e-05	0.000344	CcSEcCtD
Nelfinavir—Insomnia—Docetaxel—prostate cancer	3.89e-05	0.000343	CcSEcCtD
Nelfinavir—Arthralgia—Prednisone—prostate cancer	3.87e-05	0.000341	CcSEcCtD
Nelfinavir—Myalgia—Prednisone—prostate cancer	3.87e-05	0.000341	CcSEcCtD
Nelfinavir—Paraesthesia—Docetaxel—prostate cancer	3.87e-05	0.00034	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—prostate cancer	3.86e-05	0.00034	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—prostate cancer	3.86e-05	0.00034	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.85e-05	0.000339	CcSEcCtD
Nelfinavir—Dyspnoea—Docetaxel—prostate cancer	3.84e-05	0.000338	CcSEcCtD
Nelfinavir—Somnolence—Docetaxel—prostate cancer	3.83e-05	0.000337	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—prostate cancer	3.83e-05	0.000337	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—prostate cancer	3.82e-05	0.000336	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—prostate cancer	3.82e-05	0.000336	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—prostate cancer	3.8e-05	0.000335	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.8e-05	0.000334	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—prostate cancer	3.79e-05	0.000334	CcSEcCtD
Nelfinavir—Dyspepsia—Docetaxel—prostate cancer	3.79e-05	0.000334	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—prostate cancer	3.78e-05	0.000333	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—prostate cancer	3.78e-05	0.000333	CcSEcCtD
Nelfinavir—Insomnia—Capecitabine—prostate cancer	3.77e-05	0.000332	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—prostate cancer	3.75e-05	0.000331	CcSEcCtD
Nelfinavir—Paraesthesia—Capecitabine—prostate cancer	3.74e-05	0.00033	CcSEcCtD
Nelfinavir—Decreased appetite—Docetaxel—prostate cancer	3.74e-05	0.00033	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Docetaxel—prostate cancer	3.72e-05	0.000327	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—prostate cancer	3.72e-05	0.000327	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—prostate cancer	3.72e-05	0.000327	CcSEcCtD
Nelfinavir—Dyspnoea—Capecitabine—prostate cancer	3.72e-05	0.000327	CcSEcCtD
Nelfinavir—Oedema—Prednisone—prostate cancer	3.71e-05	0.000327	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—prostate cancer	3.71e-05	0.000327	CcSEcCtD
Nelfinavir—Nausea—Mitoxantrone—prostate cancer	3.7e-05	0.000326	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—prostate cancer	3.69e-05	0.000325	CcSEcCtD
Nelfinavir—Pain—Docetaxel—prostate cancer	3.68e-05	0.000324	CcSEcCtD
Nelfinavir—Dyspepsia—Capecitabine—prostate cancer	3.67e-05	0.000323	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—prostate cancer	3.67e-05	0.000323	CcSEcCtD
Nelfinavir—Decreased appetite—Capecitabine—prostate cancer	3.62e-05	0.000319	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—prostate cancer	3.61e-05	0.000318	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Capecitabine—prostate cancer	3.6e-05	0.000317	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—prostate cancer	3.59e-05	0.000316	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—prostate cancer	3.58e-05	0.000315	CcSEcCtD
Nelfinavir—Pain—Capecitabine—prostate cancer	3.56e-05	0.000314	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—prostate cancer	3.56e-05	0.000313	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—prostate cancer	3.56e-05	0.000313	CcSEcCtD
Nelfinavir—Feeling abnormal—Docetaxel—prostate cancer	3.55e-05	0.000312	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—prostate cancer	3.54e-05	0.000312	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—prostate cancer	3.54e-05	0.000312	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—prostate cancer	3.53e-05	0.000311	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Docetaxel—prostate cancer	3.52e-05	0.00031	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—prostate cancer	3.51e-05	0.000309	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—prostate cancer	3.44e-05	0.000303	CcSEcCtD
Nelfinavir—Feeling abnormal—Capecitabine—prostate cancer	3.44e-05	0.000303	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—prostate cancer	3.43e-05	0.000302	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—prostate cancer	3.43e-05	0.000302	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—prostate cancer	3.42e-05	0.000301	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—prostate cancer	3.42e-05	0.000301	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Capecitabine—prostate cancer	3.41e-05	0.0003	CcSEcCtD
Nelfinavir—Body temperature increased—Docetaxel—prostate cancer	3.4e-05	0.0003	CcSEcCtD
Nelfinavir—Abdominal pain—Docetaxel—prostate cancer	3.4e-05	0.0003	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—prostate cancer	3.38e-05	0.000298	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—prostate cancer	3.36e-05	0.000296	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisone—prostate cancer	3.33e-05	0.000294	CcSEcCtD
Nelfinavir—Urticaria—Capecitabine—prostate cancer	3.31e-05	0.000292	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—prostate cancer	3.3e-05	0.000291	CcSEcCtD
Nelfinavir—Body temperature increased—Capecitabine—prostate cancer	3.3e-05	0.00029	CcSEcCtD
Nelfinavir—Abdominal pain—Capecitabine—prostate cancer	3.3e-05	0.00029	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—prostate cancer	3.29e-05	0.00029	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—prostate cancer	3.29e-05	0.00029	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—prostate cancer	3.29e-05	0.00029	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—prostate cancer	3.29e-05	0.00029	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—prostate cancer	3.27e-05	0.000288	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—prostate cancer	3.27e-05	0.000288	CcSEcCtD
Nelfinavir—Rash—Etoposide—prostate cancer	3.27e-05	0.000288	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—prostate cancer	3.26e-05	0.000287	CcSEcCtD
Nelfinavir—Headache—Etoposide—prostate cancer	3.25e-05	0.000286	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—prostate cancer	3.24e-05	0.000286	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—prostate cancer	3.23e-05	0.000284	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—prostate cancer	3.21e-05	0.000283	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—prostate cancer	3.19e-05	0.00028	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—prostate cancer	3.18e-05	0.00028	CcSEcCtD
Nelfinavir—Hypersensitivity—Docetaxel—prostate cancer	3.17e-05	0.000279	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—prostate cancer	3.17e-05	0.000279	CcSEcCtD
Nelfinavir—Asthenia—Docetaxel—prostate cancer	3.09e-05	0.000272	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—prostate cancer	3.08e-05	0.000272	CcSEcCtD
Nelfinavir—Nausea—Etoposide—prostate cancer	3.08e-05	0.000271	CcSEcCtD
Nelfinavir—Hypersensitivity—Capecitabine—prostate cancer	3.07e-05	0.00027	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—prostate cancer	3.06e-05	0.000269	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—prostate cancer	3.05e-05	0.000269	CcSEcCtD
Nelfinavir—Pruritus—Docetaxel—prostate cancer	3.05e-05	0.000268	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—prostate cancer	3.04e-05	0.000268	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—prostate cancer	3.04e-05	0.000267	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—prostate cancer	3.03e-05	0.000267	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—prostate cancer	3.03e-05	0.000267	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—prostate cancer	3.03e-05	0.000266	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—prostate cancer	3.02e-05	0.000266	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.01e-05	0.000265	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—prostate cancer	2.99e-05	0.000264	CcSEcCtD
Nelfinavir—Asthenia—Capecitabine—prostate cancer	2.99e-05	0.000263	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—prostate cancer	2.97e-05	0.000261	CcSEcCtD
Nelfinavir—Urticaria—Prednisone—prostate cancer	2.95e-05	0.00026	CcSEcCtD
Nelfinavir—Pruritus—Capecitabine—prostate cancer	2.95e-05	0.00026	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—prostate cancer	2.95e-05	0.00026	CcSEcCtD
Nelfinavir—Diarrhoea—Docetaxel—prostate cancer	2.95e-05	0.000259	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—prostate cancer	2.94e-05	0.000258	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—prostate cancer	2.94e-05	0.000258	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—prostate cancer	2.9e-05	0.000256	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—prostate cancer	2.85e-05	0.000251	CcSEcCtD
Nelfinavir—Diarrhoea—Capecitabine—prostate cancer	2.85e-05	0.000251	CcSEcCtD
Nelfinavir—Dizziness—Docetaxel—prostate cancer	2.85e-05	0.000251	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—prostate cancer	2.84e-05	0.00025	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—prostate cancer	2.82e-05	0.000248	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—prostate cancer	2.81e-05	0.000247	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—prostate cancer	2.8e-05	0.000247	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—prostate cancer	2.8e-05	0.000247	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—prostate cancer	2.79e-05	0.000246	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.78e-05	0.000245	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—prostate cancer	2.77e-05	0.000244	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—prostate cancer	2.77e-05	0.000244	CcSEcCtD
Nelfinavir—Dizziness—Capecitabine—prostate cancer	2.76e-05	0.000243	CcSEcCtD
Nelfinavir—Vomiting—Docetaxel—prostate cancer	2.74e-05	0.000241	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisone—prostate cancer	2.74e-05	0.000241	CcSEcCtD
Nelfinavir—Rash—Docetaxel—prostate cancer	2.71e-05	0.000239	CcSEcCtD
Nelfinavir—Dermatitis—Docetaxel—prostate cancer	2.71e-05	0.000239	CcSEcCtD
Nelfinavir—Headache—Docetaxel—prostate cancer	2.7e-05	0.000238	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—prostate cancer	2.69e-05	0.000237	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—prostate cancer	2.66e-05	0.000235	CcSEcCtD
Nelfinavir—Vomiting—Capecitabine—prostate cancer	2.65e-05	0.000233	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.65e-05	0.000233	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—prostate cancer	2.63e-05	0.000232	CcSEcCtD
Nelfinavir—Rash—Capecitabine—prostate cancer	2.63e-05	0.000231	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—prostate cancer	2.63e-05	0.000231	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—prostate cancer	2.63e-05	0.000231	CcSEcCtD
Nelfinavir—Dermatitis—Capecitabine—prostate cancer	2.63e-05	0.000231	CcSEcCtD
Nelfinavir—Headache—Capecitabine—prostate cancer	2.61e-05	0.00023	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—prostate cancer	2.61e-05	0.00023	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—prostate cancer	2.61e-05	0.00023	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—prostate cancer	2.6e-05	0.000229	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—prostate cancer	2.59e-05	0.000228	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—prostate cancer	2.58e-05	0.000227	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—prostate cancer	2.56e-05	0.000226	CcSEcCtD
Nelfinavir—Nausea—Docetaxel—prostate cancer	2.56e-05	0.000225	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—prostate cancer	2.56e-05	0.000225	CcSEcCtD
Nelfinavir—Diarrhoea—Prednisone—prostate cancer	2.54e-05	0.000224	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—prostate cancer	2.52e-05	0.000222	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—prostate cancer	2.51e-05	0.000221	CcSEcCtD
Nelfinavir—Pain—Epirubicin—prostate cancer	2.48e-05	0.000219	CcSEcCtD
Nelfinavir—Nausea—Capecitabine—prostate cancer	2.48e-05	0.000218	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—prostate cancer	2.46e-05	0.000216	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.45e-05	0.000216	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—prostate cancer	2.43e-05	0.000214	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—prostate cancer	2.41e-05	0.000212	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—prostate cancer	2.4e-05	0.000211	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—prostate cancer	2.39e-05	0.000211	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—prostate cancer	2.39e-05	0.00021	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—prostate cancer	2.37e-05	0.000209	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—prostate cancer	2.37e-05	0.000208	CcSEcCtD
Nelfinavir—Vomiting—Prednisone—prostate cancer	2.36e-05	0.000208	CcSEcCtD
Nelfinavir—Rash—Prednisone—prostate cancer	2.34e-05	0.000206	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—prostate cancer	2.34e-05	0.000206	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—prostate cancer	2.34e-05	0.000206	CcSEcCtD
Nelfinavir—Headache—Prednisone—prostate cancer	2.33e-05	0.000205	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.32e-05	0.000204	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—prostate cancer	2.31e-05	0.000203	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—prostate cancer	2.3e-05	0.000202	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—prostate cancer	2.3e-05	0.000202	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—prostate cancer	2.3e-05	0.000202	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—prostate cancer	2.21e-05	0.000195	CcSEcCtD
Nelfinavir—Nausea—Prednisone—prostate cancer	2.21e-05	0.000194	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—prostate cancer	2.2e-05	0.000194	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—prostate cancer	2.14e-05	0.000188	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—prostate cancer	2.13e-05	0.000188	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—prostate cancer	2.12e-05	0.000187	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—prostate cancer	2.12e-05	0.000187	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—prostate cancer	2.08e-05	0.000183	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—prostate cancer	2.05e-05	0.000181	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—prostate cancer	1.99e-05	0.000175	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—prostate cancer	1.98e-05	0.000174	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—prostate cancer	1.93e-05	0.00017	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—prostate cancer	1.92e-05	0.000169	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—prostate cancer	1.9e-05	0.000167	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—prostate cancer	1.85e-05	0.000163	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—prostate cancer	1.84e-05	0.000162	CcSEcCtD
Nelfinavir—Rash—Epirubicin—prostate cancer	1.83e-05	0.000161	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—prostate cancer	1.83e-05	0.000161	CcSEcCtD
Nelfinavir—Headache—Epirubicin—prostate cancer	1.82e-05	0.00016	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—prostate cancer	1.78e-05	0.000156	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—prostate cancer	1.72e-05	0.000152	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—prostate cancer	1.71e-05	0.00015	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—prostate cancer	1.69e-05	0.000149	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—prostate cancer	1.69e-05	0.000149	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—prostate cancer	1.68e-05	0.000148	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—prostate cancer	1.6e-05	0.000141	CcSEcCtD
Nelfinavir—CYP2B6—Metabolism—PPARA—prostate cancer	1.86e-06	2.28e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CREBBP—prostate cancer	1.86e-06	2.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—P4HB—prostate cancer	1.85e-06	2.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MTHFR—prostate cancer	1.85e-06	2.27e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.85e-06	2.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.85e-06	2.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—RXRA—prostate cancer	1.84e-06	2.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARA—prostate cancer	1.82e-06	2.23e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—prostate cancer	1.82e-06	2.23e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GGT1—prostate cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NOS3—prostate cancer	1.8e-06	2.21e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CB—prostate cancer	1.8e-06	2.21e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—RXRA—prostate cancer	1.79e-06	2.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GGT1—prostate cancer	1.79e-06	2.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.79e-06	2.2e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NCOA2—prostate cancer	1.79e-06	2.19e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NOS3—prostate cancer	1.79e-06	2.19e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—prostate cancer	1.78e-06	2.19e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NCOA1—prostate cancer	1.78e-06	2.18e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—COMT—prostate cancer	1.77e-06	2.17e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTP1—prostate cancer	1.76e-06	2.16e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NCOA1—prostate cancer	1.76e-06	2.16e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CD—prostate cancer	1.76e-06	2.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.76e-06	2.16e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.75e-06	2.15e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CAV1—prostate cancer	1.75e-06	2.15e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ITPR1—prostate cancer	1.73e-06	2.13e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—EP300—prostate cancer	1.73e-06	2.13e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MED12—prostate cancer	1.73e-06	2.12e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—COMT—prostate cancer	1.73e-06	2.12e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTP1—prostate cancer	1.72e-06	2.11e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GNG5—prostate cancer	1.72e-06	2.11e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CAV1—prostate cancer	1.71e-06	2.1e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.7e-06	2.09e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.7e-06	2.09e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ITPR1—prostate cancer	1.69e-06	2.08e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—RXRA—prostate cancer	1.69e-06	2.08e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—RXRA—prostate cancer	1.68e-06	2.06e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CB—prostate cancer	1.66e-06	2.04e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NOS3—prostate cancer	1.66e-06	2.04e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOA3—prostate cancer	1.65e-06	2.03e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.65e-06	2.03e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—prostate cancer	1.65e-06	2.02e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NQO1—prostate cancer	1.65e-06	2.02e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TYMS—prostate cancer	1.64e-06	2.01e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—prostate cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.63e-06	2e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—COMT—prostate cancer	1.63e-06	2e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TH—prostate cancer	1.62e-06	1.99e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTP1—prostate cancer	1.62e-06	1.99e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—prostate cancer	1.62e-06	1.99e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—COMT—prostate cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTP1—prostate cancer	1.61e-06	1.97e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.61e-06	1.97e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TYMS—prostate cancer	1.6e-06	1.96e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.6e-06	1.96e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ITPR1—prostate cancer	1.59e-06	1.96e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.59e-06	1.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—LPL—prostate cancer	1.59e-06	1.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ITPR1—prostate cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—prostate cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HPGDS—prostate cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.57e-06	1.92e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.56e-06	1.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—prostate cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—LPL—prostate cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.54e-06	1.89e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ACHE—prostate cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTT1—prostate cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GGT1—prostate cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ERCC2—prostate cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—prostate cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.51e-06	1.86e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TYMS—prostate cancer	1.51e-06	1.85e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—INS—prostate cancer	1.51e-06	1.85e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NCOA1—prostate cancer	1.51e-06	1.85e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1A1—prostate cancer	1.5e-06	1.84e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TYMS—prostate cancer	1.49e-06	1.83e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—prostate cancer	1.49e-06	1.83e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ERCC2—prostate cancer	1.49e-06	1.83e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.48e-06	1.82e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—EP300—prostate cancer	1.48e-06	1.82e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—prostate cancer	1.48e-06	1.81e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CREBBP—prostate cancer	1.48e-06	1.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—INS—prostate cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PRKACB—prostate cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—LPL—prostate cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—LPL—prostate cancer	1.45e-06	1.78e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.45e-06	1.78e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CREBBP—prostate cancer	1.44e-06	1.77e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—prostate cancer	1.44e-06	1.77e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—RXRA—prostate cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MTHFR—prostate cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—prostate cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.41e-06	1.73e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARA—prostate cancer	1.4e-06	1.72e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ERCC2—prostate cancer	1.4e-06	1.72e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.4e-06	1.72e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.4e-06	1.72e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MTHFR—prostate cancer	1.4e-06	1.72e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.39e-06	1.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ERCC2—prostate cancer	1.39e-06	1.71e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—COMT—prostate cancer	1.38e-06	1.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOA2—prostate cancer	1.38e-06	1.69e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTP1—prostate cancer	1.37e-06	1.69e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—EP300—prostate cancer	1.37e-06	1.68e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARA—prostate cancer	1.37e-06	1.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.37e-06	1.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—EP300—prostate cancer	1.36e-06	1.67e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ITPR1—prostate cancer	1.35e-06	1.66e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—prostate cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NOS3—prostate cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CAV1—prostate cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MTHFR—prostate cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MTHFR—prostate cancer	1.3e-06	1.6e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARA—prostate cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NOS3—prostate cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CAV1—prostate cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.28e-06	1.57e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARA—prostate cancer	1.28e-06	1.57e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TYMS—prostate cancer	1.28e-06	1.57e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NQO1—prostate cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—EP300—prostate cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—prostate cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TH—prostate cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—LPL—prostate cancer	1.24e-06	1.52e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CAV1—prostate cancer	1.21e-06	1.49e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—prostate cancer	1.21e-06	1.48e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CAV1—prostate cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.2e-06	1.47e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ERCC2—prostate cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—prostate cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GGT1—prostate cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—prostate cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOA1—prostate cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.15e-06	1.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.15e-06	1.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—INS—prostate cancer	1.14e-06	1.4e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTHFR—prostate cancer	1.12e-06	1.37e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CREBBP—prostate cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—INS—prostate cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—RXRA—prostate cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARA—prostate cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CREBBP—prostate cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—COMT—prostate cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTP1—prostate cancer	1.06e-06	1.3e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.06e-06	1.3e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—prostate cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—INS—prostate cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—prostate cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ITPR1—prostate cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—INS—prostate cancer	1.04e-06	1.27e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CD—prostate cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—prostate cancer	1.03e-06	1.26e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CAV1—prostate cancer	1.03e-06	1.26e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CREBBP—prostate cancer	1.03e-06	1.26e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CREBBP—prostate cancer	1.02e-06	1.25e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—prostate cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—prostate cancer	1e-06	1.23e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—EP300—prostate cancer	1e-06	1.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NOS3—prostate cancer	9.98e-07	1.23e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TYMS—prostate cancer	9.85e-07	1.21e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.83e-07	1.21e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—EP300—prostate cancer	9.82e-07	1.21e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NOS3—prostate cancer	9.74e-07	1.2e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—prostate cancer	9.74e-07	1.2e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CD—prostate cancer	9.72e-07	1.19e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CD—prostate cancer	9.64e-07	1.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—LPL—prostate cancer	9.56e-07	1.17e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—prostate cancer	9.37e-07	1.15e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—prostate cancer	9.35e-07	1.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.23e-07	1.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.21e-07	1.13e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NOS3—prostate cancer	9.18e-07	1.13e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ERCC2—prostate cancer	9.15e-07	1.12e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—prostate cancer	9.13e-07	1.12e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NOS3—prostate cancer	9.1e-07	1.12e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CB—prostate cancer	8.99e-07	1.1e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—prostate cancer	8.95e-07	1.1e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—prostate cancer	8.91e-07	1.09e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—INS—prostate cancer	8.87e-07	1.09e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CREBBP—prostate cancer	8.69e-07	1.07e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTHFR—prostate cancer	8.61e-07	1.06e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CB—prostate cancer	8.47e-07	1.04e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARA—prostate cancer	8.44e-07	1.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CB—prostate cancer	8.4e-07	1.03e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—prostate cancer	8.4e-07	1.03e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—prostate cancer	8.32e-07	1.02e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—prostate cancer	8.28e-07	1.02e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CD—prostate cancer	8.24e-07	1.01e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—prostate cancer	8.21e-07	1.01e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—prostate cancer	7.96e-07	9.78e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CAV1—prostate cancer	7.94e-07	9.75e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NOS3—prostate cancer	7.78e-07	9.55e-06	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—prostate cancer	7.77e-07	9.55e-06	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—prostate cancer	7.64e-07	9.39e-06	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—EP300—prostate cancer	7.59e-07	9.33e-06	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—prostate cancer	7.43e-07	9.13e-06	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—EP300—prostate cancer	7.41e-07	9.1e-06	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—prostate cancer	7.32e-07	8.99e-06	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—prostate cancer	7.26e-07	8.92e-06	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—prostate cancer	7.26e-07	8.92e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.23e-07	8.88e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CB—prostate cancer	7.18e-07	8.82e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—prostate cancer	7.11e-07	8.74e-06	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—EP300—prostate cancer	6.98e-07	8.58e-06	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—EP300—prostate cancer	6.92e-07	8.5e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—INS—prostate cancer	6.84e-07	8.41e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CREBBP—prostate cancer	6.7e-07	8.23e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.36e-07	7.81e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—prostate cancer	6.2e-07	7.62e-06	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—prostate cancer	6.07e-07	7.46e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NOS3—prostate cancer	6e-07	7.37e-06	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—prostate cancer	5.93e-07	7.29e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—EP300—prostate cancer	5.92e-07	7.27e-06	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.62e-07	6.9e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.54e-07	6.81e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—prostate cancer	5.49e-07	6.74e-06	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—prostate cancer	5.48e-07	6.73e-06	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.17e-07	6.35e-06	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.12e-07	6.29e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—prostate cancer	4.79e-07	5.88e-06	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—prostate cancer	4.59e-07	5.64e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—EP300—prostate cancer	4.57e-07	5.61e-06	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—prostate cancer	4.48e-07	5.5e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.38e-07	5.38e-06	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—prostate cancer	4.22e-07	5.18e-06	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—prostate cancer	4.18e-07	5.14e-06	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—prostate cancer	3.57e-07	4.39e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.38e-07	4.15e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—prostate cancer	2.76e-07	3.39e-06	CbGpPWpGaD
